GV, the venture capital arm of Alphabet, spends little time focusing on direct patient care or purely technological healthcare solutions, instead concentrating on hospital infrastructure and intersections with pharma, GV venture partner Ben Robbins, MD, told the American Journal of Managed Care in an interview published July 11.
